Global Kidney Disease Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Kidney Disease Drugs Industry Forecast” looks at past sales and reviews total world Kidney Disease Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Kidney Disease Drugs sales for 2023 through 2029. With Kidney Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Kidney Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Kidney Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Kidney Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Disease Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Disease Drugs.
The global Kidney Disease Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Kidney Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Kidney Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Kidney Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Kidney Disease Drugs players cover GlaxoSmithKline, Sanofi, Roche, Pfizer, AstraZeneca, Keryx Biopharmaceuticals, Kissei Pharmaceutical, AbbVie and Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Kidney Disease Drugs market?
What factors are driving Kidney Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Kidney Disease Drugs market opportunities vary by end market size?
How does Kidney Disease Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Kidney Disease Drugs Industry Forecast” looks at past sales and reviews total world Kidney Disease Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Kidney Disease Drugs sales for 2023 through 2029. With Kidney Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Kidney Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Kidney Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Kidney Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Disease Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Disease Drugs.
The global Kidney Disease Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Kidney Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Kidney Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Kidney Disease Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Kidney Disease Drugs players cover GlaxoSmithKline, Sanofi, Roche, Pfizer, AstraZeneca, Keryx Biopharmaceuticals, Kissei Pharmaceutical, AbbVie and Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablets
- Capsule
- Other
- Chronic Glomerulonephritis
- Nephrotic Syndrome
- Chronic Renal Failure
- Kidney Stones
- Renal Cyst (polycystic Kidney)
- Diabetic Nephropathy
- Hypertensive Nephropathy
- Purpura Nephritis
- Lupus Nephritis
- Pediatric Kidney Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Sanofi
- Roche
- Pfizer
- AstraZeneca
- Keryx Biopharmaceuticals
- Kissei Pharmaceutical
- AbbVie
- Amgen
- Teva Pharmaceutical Industries
- Tianjin Tongrentang Group
- Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
- Datong Liqun Pharmaceutical
- Hebei Ruisen Pharmaceutical
- Changxing Pharmaceutical
- zhejiang Shengbokang Pharmaceutical
What is the 10-year outlook for the global Kidney Disease Drugs market?
What factors are driving Kidney Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Kidney Disease Drugs market opportunities vary by end market size?
How does Kidney Disease Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Kidney Disease Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Kidney Disease Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Kidney Disease Drugs by Country/Region, 2018, 2022 & 2029
2.2 Kidney Disease Drugs Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Other
2.3 Kidney Disease Drugs Sales by Type
2.3.1 Global Kidney Disease Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Kidney Disease Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Kidney Disease Drugs Sale Price by Type (2018-2023)
2.4 Kidney Disease Drugs Segment by Application
2.4.1 Chronic Glomerulonephritis
2.4.2 Nephrotic Syndrome
2.4.3 Chronic Renal Failure
2.4.4 Kidney Stones
2.4.5 Renal Cyst (polycystic Kidney)
2.4.6 Diabetic Nephropathy
2.4.7 Hypertensive Nephropathy
2.4.8 Purpura Nephritis
2.4.9 Lupus Nephritis
2.4.10 Pediatric Kidney Disease
2.5 Kidney Disease Drugs Sales by Application
2.5.1 Global Kidney Disease Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Kidney Disease Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Kidney Disease Drugs Sale Price by Application (2018-2023)
3 GLOBAL KIDNEY DISEASE DRUGS BY COMPANY
3.1 Global Kidney Disease Drugs Breakdown Data by Company
3.1.1 Global Kidney Disease Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Kidney Disease Drugs Sales Market Share by Company (2018-2023)
3.2 Global Kidney Disease Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Kidney Disease Drugs Revenue by Company (2018-2023)
3.2.2 Global Kidney Disease Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Kidney Disease Drugs Sale Price by Company
3.4 Key Manufacturers Kidney Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Kidney Disease Drugs Product Location Distribution
3.4.2 Players Kidney Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR KIDNEY DISEASE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Kidney Disease Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Kidney Disease Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Kidney Disease Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Kidney Disease Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Kidney Disease Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Kidney Disease Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Kidney Disease Drugs Sales Growth
4.4 APAC Kidney Disease Drugs Sales Growth
4.5 Europe Kidney Disease Drugs Sales Growth
4.6 Middle East & Africa Kidney Disease Drugs Sales Growth
5 AMERICAS
5.1 Americas Kidney Disease Drugs Sales by Country
5.1.1 Americas Kidney Disease Drugs Sales by Country (2018-2023)
5.1.2 Americas Kidney Disease Drugs Revenue by Country (2018-2023)
5.2 Americas Kidney Disease Drugs Sales by Type
5.3 Americas Kidney Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Kidney Disease Drugs Sales by Region
6.1.1 APAC Kidney Disease Drugs Sales by Region (2018-2023)
6.1.2 APAC Kidney Disease Drugs Revenue by Region (2018-2023)
6.2 APAC Kidney Disease Drugs Sales by Type
6.3 APAC Kidney Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Kidney Disease Drugs by Country
7.1.1 Europe Kidney Disease Drugs Sales by Country (2018-2023)
7.1.2 Europe Kidney Disease Drugs Revenue by Country (2018-2023)
7.2 Europe Kidney Disease Drugs Sales by Type
7.3 Europe Kidney Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Kidney Disease Drugs by Country
8.1.1 Middle East & Africa Kidney Disease Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Kidney Disease Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Kidney Disease Drugs Sales by Type
8.3 Middle East & Africa Kidney Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Kidney Disease Drugs
10.3 Manufacturing Process Analysis of Kidney Disease Drugs
10.4 Industry Chain Structure of Kidney Disease Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Kidney Disease Drugs Distributors
11.3 Kidney Disease Drugs Customer
12 WORLD FORECAST REVIEW FOR KIDNEY DISEASE DRUGS BY GEOGRAPHIC REGION
12.1 Global Kidney Disease Drugs Market Size Forecast by Region
12.1.1 Global Kidney Disease Drugs Forecast by Region (2024-2029)
12.1.2 Global Kidney Disease Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Kidney Disease Drugs Forecast by Type
12.7 Global Kidney Disease Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Kidney Disease Drugs Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Kidney Disease Drugs Product Portfolios and Specifications
13.2.3 Sanofi Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Kidney Disease Drugs Product Portfolios and Specifications
13.3.3 Roche Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Kidney Disease Drugs Product Portfolios and Specifications
13.4.3 Pfizer Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Kidney Disease Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Keryx Biopharmaceuticals
13.6.1 Keryx Biopharmaceuticals Company Information
13.6.2 Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolios and Specifications
13.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Keryx Biopharmaceuticals Main Business Overview
13.6.5 Keryx Biopharmaceuticals Latest Developments
13.7 Kissei Pharmaceutical
13.7.1 Kissei Pharmaceutical Company Information
13.7.2 Kissei Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kissei Pharmaceutical Main Business Overview
13.7.5 Kissei Pharmaceutical Latest Developments
13.8 AbbVie
13.8.1 AbbVie Company Information
13.8.2 AbbVie Kidney Disease Drugs Product Portfolios and Specifications
13.8.3 AbbVie Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AbbVie Main Business Overview
13.8.5 AbbVie Latest Developments
13.9 Amgen
13.9.1 Amgen Company Information
13.9.2 Amgen Kidney Disease Drugs Product Portfolios and Specifications
13.9.3 Amgen Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Amgen Main Business Overview
13.9.5 Amgen Latest Developments
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Information
13.10.2 Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Pharmaceutical Industries Main Business Overview
13.10.5 Teva Pharmaceutical Industries Latest Developments
13.11 Tianjin Tongrentang Group
13.11.1 Tianjin Tongrentang Group Company Information
13.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolios and Specifications
13.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tianjin Tongrentang Group Main Business Overview
13.11.5 Tianjin Tongrentang Group Latest Developments
13.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
13.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Information
13.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Business Overview
13.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Latest Developments
13.13 Datong Liqun Pharmaceutical
13.13.1 Datong Liqun Pharmaceutical Company Information
13.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Datong Liqun Pharmaceutical Main Business Overview
13.13.5 Datong Liqun Pharmaceutical Latest Developments
13.14 Hebei Ruisen Pharmaceutical
13.14.1 Hebei Ruisen Pharmaceutical Company Information
13.14.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hebei Ruisen Pharmaceutical Main Business Overview
13.14.5 Hebei Ruisen Pharmaceutical Latest Developments
13.15 Changxing Pharmaceutical
13.15.1 Changxing Pharmaceutical Company Information
13.15.2 Changxing Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Changxing Pharmaceutical Main Business Overview
13.15.5 Changxing Pharmaceutical Latest Developments
13.16 zhejiang Shengbokang Pharmaceutical
13.16.1 zhejiang Shengbokang Pharmaceutical Company Information
13.16.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 zhejiang Shengbokang Pharmaceutical Main Business Overview
13.16.5 zhejiang Shengbokang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Kidney Disease Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Kidney Disease Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Kidney Disease Drugs by Country/Region, 2018, 2022 & 2029
2.2 Kidney Disease Drugs Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.2.3 Other
2.3 Kidney Disease Drugs Sales by Type
2.3.1 Global Kidney Disease Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Kidney Disease Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Kidney Disease Drugs Sale Price by Type (2018-2023)
2.4 Kidney Disease Drugs Segment by Application
2.4.1 Chronic Glomerulonephritis
2.4.2 Nephrotic Syndrome
2.4.3 Chronic Renal Failure
2.4.4 Kidney Stones
2.4.5 Renal Cyst (polycystic Kidney)
2.4.6 Diabetic Nephropathy
2.4.7 Hypertensive Nephropathy
2.4.8 Purpura Nephritis
2.4.9 Lupus Nephritis
2.4.10 Pediatric Kidney Disease
2.5 Kidney Disease Drugs Sales by Application
2.5.1 Global Kidney Disease Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Kidney Disease Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Kidney Disease Drugs Sale Price by Application (2018-2023)
3 GLOBAL KIDNEY DISEASE DRUGS BY COMPANY
3.1 Global Kidney Disease Drugs Breakdown Data by Company
3.1.1 Global Kidney Disease Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Kidney Disease Drugs Sales Market Share by Company (2018-2023)
3.2 Global Kidney Disease Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Kidney Disease Drugs Revenue by Company (2018-2023)
3.2.2 Global Kidney Disease Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Kidney Disease Drugs Sale Price by Company
3.4 Key Manufacturers Kidney Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Kidney Disease Drugs Product Location Distribution
3.4.2 Players Kidney Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR KIDNEY DISEASE DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Kidney Disease Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Kidney Disease Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Kidney Disease Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Kidney Disease Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Kidney Disease Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Kidney Disease Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Kidney Disease Drugs Sales Growth
4.4 APAC Kidney Disease Drugs Sales Growth
4.5 Europe Kidney Disease Drugs Sales Growth
4.6 Middle East & Africa Kidney Disease Drugs Sales Growth
5 AMERICAS
5.1 Americas Kidney Disease Drugs Sales by Country
5.1.1 Americas Kidney Disease Drugs Sales by Country (2018-2023)
5.1.2 Americas Kidney Disease Drugs Revenue by Country (2018-2023)
5.2 Americas Kidney Disease Drugs Sales by Type
5.3 Americas Kidney Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Kidney Disease Drugs Sales by Region
6.1.1 APAC Kidney Disease Drugs Sales by Region (2018-2023)
6.1.2 APAC Kidney Disease Drugs Revenue by Region (2018-2023)
6.2 APAC Kidney Disease Drugs Sales by Type
6.3 APAC Kidney Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Kidney Disease Drugs by Country
7.1.1 Europe Kidney Disease Drugs Sales by Country (2018-2023)
7.1.2 Europe Kidney Disease Drugs Revenue by Country (2018-2023)
7.2 Europe Kidney Disease Drugs Sales by Type
7.3 Europe Kidney Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Kidney Disease Drugs by Country
8.1.1 Middle East & Africa Kidney Disease Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Kidney Disease Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Kidney Disease Drugs Sales by Type
8.3 Middle East & Africa Kidney Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Kidney Disease Drugs
10.3 Manufacturing Process Analysis of Kidney Disease Drugs
10.4 Industry Chain Structure of Kidney Disease Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Kidney Disease Drugs Distributors
11.3 Kidney Disease Drugs Customer
12 WORLD FORECAST REVIEW FOR KIDNEY DISEASE DRUGS BY GEOGRAPHIC REGION
12.1 Global Kidney Disease Drugs Market Size Forecast by Region
12.1.1 Global Kidney Disease Drugs Forecast by Region (2024-2029)
12.1.2 Global Kidney Disease Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Kidney Disease Drugs Forecast by Type
12.7 Global Kidney Disease Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Kidney Disease Drugs Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Kidney Disease Drugs Product Portfolios and Specifications
13.2.3 Sanofi Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Kidney Disease Drugs Product Portfolios and Specifications
13.3.3 Roche Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Kidney Disease Drugs Product Portfolios and Specifications
13.4.3 Pfizer Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Kidney Disease Drugs Product Portfolios and Specifications
13.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Keryx Biopharmaceuticals
13.6.1 Keryx Biopharmaceuticals Company Information
13.6.2 Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolios and Specifications
13.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Keryx Biopharmaceuticals Main Business Overview
13.6.5 Keryx Biopharmaceuticals Latest Developments
13.7 Kissei Pharmaceutical
13.7.1 Kissei Pharmaceutical Company Information
13.7.2 Kissei Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Kissei Pharmaceutical Main Business Overview
13.7.5 Kissei Pharmaceutical Latest Developments
13.8 AbbVie
13.8.1 AbbVie Company Information
13.8.2 AbbVie Kidney Disease Drugs Product Portfolios and Specifications
13.8.3 AbbVie Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AbbVie Main Business Overview
13.8.5 AbbVie Latest Developments
13.9 Amgen
13.9.1 Amgen Company Information
13.9.2 Amgen Kidney Disease Drugs Product Portfolios and Specifications
13.9.3 Amgen Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Amgen Main Business Overview
13.9.5 Amgen Latest Developments
13.10 Teva Pharmaceutical Industries
13.10.1 Teva Pharmaceutical Industries Company Information
13.10.2 Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Pharmaceutical Industries Main Business Overview
13.10.5 Teva Pharmaceutical Industries Latest Developments
13.11 Tianjin Tongrentang Group
13.11.1 Tianjin Tongrentang Group Company Information
13.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolios and Specifications
13.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tianjin Tongrentang Group Main Business Overview
13.11.5 Tianjin Tongrentang Group Latest Developments
13.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
13.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Information
13.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Business Overview
13.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Latest Developments
13.13 Datong Liqun Pharmaceutical
13.13.1 Datong Liqun Pharmaceutical Company Information
13.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Datong Liqun Pharmaceutical Main Business Overview
13.13.5 Datong Liqun Pharmaceutical Latest Developments
13.14 Hebei Ruisen Pharmaceutical
13.14.1 Hebei Ruisen Pharmaceutical Company Information
13.14.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hebei Ruisen Pharmaceutical Main Business Overview
13.14.5 Hebei Ruisen Pharmaceutical Latest Developments
13.15 Changxing Pharmaceutical
13.15.1 Changxing Pharmaceutical Company Information
13.15.2 Changxing Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Changxing Pharmaceutical Main Business Overview
13.15.5 Changxing Pharmaceutical Latest Developments
13.16 zhejiang Shengbokang Pharmaceutical
13.16.1 zhejiang Shengbokang Pharmaceutical Company Information
13.16.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
13.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 zhejiang Shengbokang Pharmaceutical Main Business Overview
13.16.5 zhejiang Shengbokang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Kidney Disease Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Kidney Disease Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsule
Table 5. Major Players of Other
Table 6. Global Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 7. Global Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Table 8. Global Kidney Disease Drugs Revenue by Type (2018-2023) & ($ million)
Table 9. Global Kidney Disease Drugs Revenue Market Share by Type (2018-2023)
Table 10. Global Kidney Disease Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 12. Global Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Table 13. Global Kidney Disease Drugs Revenue by Application (2018-2023)
Table 14. Global Kidney Disease Drugs Revenue Market Share by Application (2018-2023)
Table 15. Global Kidney Disease Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Kidney Disease Drugs Sales by Company (2018-2023) & (K Units)
Table 17. Global Kidney Disease Drugs Sales Market Share by Company (2018-2023)
Table 18. Global Kidney Disease Drugs Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Kidney Disease Drugs Revenue Market Share by Company (2018-2023)
Table 20. Global Kidney Disease Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Kidney Disease Drugs Producing Area Distribution and Sales Area
Table 22. Players Kidney Disease Drugs Products Offered
Table 23. Kidney Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Kidney Disease Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Kidney Disease Drugs Sales Market Share Geographic Region (2018-2023)
Table 28. Global Kidney Disease Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Kidney Disease Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Kidney Disease Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Kidney Disease Drugs Sales Market Share by Country/Region (2018-2023)
Table 32. Global Kidney Disease Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Kidney Disease Drugs Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Kidney Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 35. Americas Kidney Disease Drugs Sales Market Share by Country (2018-2023)
Table 36. Americas Kidney Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Kidney Disease Drugs Revenue Market Share by Country (2018-2023)
Table 38. Americas Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 39. Americas Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 40. APAC Kidney Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 41. APAC Kidney Disease Drugs Sales Market Share by Region (2018-2023)
Table 42. APAC Kidney Disease Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Kidney Disease Drugs Revenue Market Share by Region (2018-2023)
Table 44. APAC Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 45. APAC Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 46. Europe Kidney Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Europe Kidney Disease Drugs Sales Market Share by Country (2018-2023)
Table 48. Europe Kidney Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Kidney Disease Drugs Revenue Market Share by Country (2018-2023)
Table 50. Europe Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 51. Europe Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Kidney Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Kidney Disease Drugs Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Kidney Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Kidney Disease Drugs
Table 59. Key Market Challenges & Risks of Kidney Disease Drugs
Table 60. Key Industry Trends of Kidney Disease Drugs
Table 61. Kidney Disease Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Kidney Disease Drugs Distributors List
Table 64. Kidney Disease Drugs Customer List
Table 65. Global Kidney Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Kidney Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Kidney Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Kidney Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Kidney Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Kidney Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Kidney Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Kidney Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Kidney Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Kidney Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Kidney Disease Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Kidney Disease Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Kidney Disease Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Kidney Disease Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GlaxoSmithKline Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline Kidney Disease Drugs Product Portfolios and Specifications
Table 81. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Latest Developments
Table 84. Sanofi Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Kidney Disease Drugs Product Portfolios and Specifications
Table 86. Sanofi Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Roche Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Kidney Disease Drugs Product Portfolios and Specifications
Table 91. Roche Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Pfizer Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Kidney Disease Drugs Product Portfolios and Specifications
Table 96. Pfizer Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. AstraZeneca Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca Kidney Disease Drugs Product Portfolios and Specifications
Table 101. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Keryx Biopharmaceuticals Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolios and Specifications
Table 106. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Keryx Biopharmaceuticals Main Business
Table 108. Keryx Biopharmaceuticals Latest Developments
Table 109. Kissei Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Kissei Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 111. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Kissei Pharmaceutical Main Business
Table 113. Kissei Pharmaceutical Latest Developments
Table 114. AbbVie Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. AbbVie Kidney Disease Drugs Product Portfolios and Specifications
Table 116. AbbVie Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. AbbVie Main Business
Table 118. AbbVie Latest Developments
Table 119. Amgen Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Amgen Kidney Disease Drugs Product Portfolios and Specifications
Table 121. Amgen Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Amgen Main Business
Table 123. Amgen Latest Developments
Table 124. Teva Pharmaceutical Industries Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolios and Specifications
Table 126. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Teva Pharmaceutical Industries Main Business
Table 128. Teva Pharmaceutical Industries Latest Developments
Table 129. Tianjin Tongrentang Group Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolios and Specifications
Table 131. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Tianjin Tongrentang Group Main Business
Table 133. Tianjin Tongrentang Group Latest Developments
Table 134. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 136. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Business
Table 138. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Latest Developments
Table 139. Datong Liqun Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 141. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Datong Liqun Pharmaceutical Main Business
Table 143. Datong Liqun Pharmaceutical Latest Developments
Table 144. Hebei Ruisen Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 146. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Hebei Ruisen Pharmaceutical Main Business
Table 148. Hebei Ruisen Pharmaceutical Latest Developments
Table 149. Changxing Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Changxing Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 151. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Changxing Pharmaceutical Main Business
Table 153. Changxing Pharmaceutical Latest Developments
Table 154. zhejiang Shengbokang Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 156. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. zhejiang Shengbokang Pharmaceutical Main Business
Table 158. zhejiang Shengbokang Pharmaceutical Latest Developments
Table 1. Kidney Disease Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Kidney Disease Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsule
Table 5. Major Players of Other
Table 6. Global Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 7. Global Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Table 8. Global Kidney Disease Drugs Revenue by Type (2018-2023) & ($ million)
Table 9. Global Kidney Disease Drugs Revenue Market Share by Type (2018-2023)
Table 10. Global Kidney Disease Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 12. Global Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Table 13. Global Kidney Disease Drugs Revenue by Application (2018-2023)
Table 14. Global Kidney Disease Drugs Revenue Market Share by Application (2018-2023)
Table 15. Global Kidney Disease Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Kidney Disease Drugs Sales by Company (2018-2023) & (K Units)
Table 17. Global Kidney Disease Drugs Sales Market Share by Company (2018-2023)
Table 18. Global Kidney Disease Drugs Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Kidney Disease Drugs Revenue Market Share by Company (2018-2023)
Table 20. Global Kidney Disease Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Kidney Disease Drugs Producing Area Distribution and Sales Area
Table 22. Players Kidney Disease Drugs Products Offered
Table 23. Kidney Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Kidney Disease Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Kidney Disease Drugs Sales Market Share Geographic Region (2018-2023)
Table 28. Global Kidney Disease Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Kidney Disease Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Kidney Disease Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Kidney Disease Drugs Sales Market Share by Country/Region (2018-2023)
Table 32. Global Kidney Disease Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Kidney Disease Drugs Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Kidney Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 35. Americas Kidney Disease Drugs Sales Market Share by Country (2018-2023)
Table 36. Americas Kidney Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Kidney Disease Drugs Revenue Market Share by Country (2018-2023)
Table 38. Americas Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 39. Americas Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 40. APAC Kidney Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 41. APAC Kidney Disease Drugs Sales Market Share by Region (2018-2023)
Table 42. APAC Kidney Disease Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Kidney Disease Drugs Revenue Market Share by Region (2018-2023)
Table 44. APAC Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 45. APAC Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 46. Europe Kidney Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Europe Kidney Disease Drugs Sales Market Share by Country (2018-2023)
Table 48. Europe Kidney Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Kidney Disease Drugs Revenue Market Share by Country (2018-2023)
Table 50. Europe Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 51. Europe Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Kidney Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Kidney Disease Drugs Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Kidney Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Kidney Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Kidney Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Kidney Disease Drugs
Table 59. Key Market Challenges & Risks of Kidney Disease Drugs
Table 60. Key Industry Trends of Kidney Disease Drugs
Table 61. Kidney Disease Drugs Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Kidney Disease Drugs Distributors List
Table 64. Kidney Disease Drugs Customer List
Table 65. Global Kidney Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Kidney Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Kidney Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Kidney Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Kidney Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Kidney Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Kidney Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Kidney Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Kidney Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Kidney Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Kidney Disease Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Kidney Disease Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Kidney Disease Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Kidney Disease Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GlaxoSmithKline Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline Kidney Disease Drugs Product Portfolios and Specifications
Table 81. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Latest Developments
Table 84. Sanofi Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Kidney Disease Drugs Product Portfolios and Specifications
Table 86. Sanofi Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Roche Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Kidney Disease Drugs Product Portfolios and Specifications
Table 91. Roche Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Pfizer Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Kidney Disease Drugs Product Portfolios and Specifications
Table 96. Pfizer Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. AstraZeneca Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. AstraZeneca Kidney Disease Drugs Product Portfolios and Specifications
Table 101. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Latest Developments
Table 104. Keryx Biopharmaceuticals Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolios and Specifications
Table 106. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Keryx Biopharmaceuticals Main Business
Table 108. Keryx Biopharmaceuticals Latest Developments
Table 109. Kissei Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Kissei Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 111. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Kissei Pharmaceutical Main Business
Table 113. Kissei Pharmaceutical Latest Developments
Table 114. AbbVie Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. AbbVie Kidney Disease Drugs Product Portfolios and Specifications
Table 116. AbbVie Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. AbbVie Main Business
Table 118. AbbVie Latest Developments
Table 119. Amgen Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Amgen Kidney Disease Drugs Product Portfolios and Specifications
Table 121. Amgen Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Amgen Main Business
Table 123. Amgen Latest Developments
Table 124. Teva Pharmaceutical Industries Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolios and Specifications
Table 126. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Teva Pharmaceutical Industries Main Business
Table 128. Teva Pharmaceutical Industries Latest Developments
Table 129. Tianjin Tongrentang Group Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolios and Specifications
Table 131. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Tianjin Tongrentang Group Main Business
Table 133. Tianjin Tongrentang Group Latest Developments
Table 134. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 136. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Business
Table 138. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Latest Developments
Table 139. Datong Liqun Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 141. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Datong Liqun Pharmaceutical Main Business
Table 143. Datong Liqun Pharmaceutical Latest Developments
Table 144. Hebei Ruisen Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 146. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Hebei Ruisen Pharmaceutical Main Business
Table 148. Hebei Ruisen Pharmaceutical Latest Developments
Table 149. Changxing Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Changxing Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 151. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Changxing Pharmaceutical Main Business
Table 153. Changxing Pharmaceutical Latest Developments
Table 154. zhejiang Shengbokang Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolios and Specifications
Table 156. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. zhejiang Shengbokang Pharmaceutical Main Business
Table 158. zhejiang Shengbokang Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Kidney Disease Drugs
Figure 2. Kidney Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Kidney Disease Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Kidney Disease Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Kidney Disease Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsule
Figure 11. Product Picture of Other
Figure 12. Global Kidney Disease Drugs Sales Market Share by Type in 2022
Figure 13. Global Kidney Disease Drugs Revenue Market Share by Type (2018-2023)
Figure 14. Kidney Disease Drugs Consumed in Chronic Glomerulonephritis
Figure 15. Global Kidney Disease Drugs Market: Chronic Glomerulonephritis (2018-2023) & (K Units)
Figure 16. Kidney Disease Drugs Consumed in Nephrotic Syndrome
Figure 17. Global Kidney Disease Drugs Market: Nephrotic Syndrome (2018-2023) & (K Units)
Figure 18. Kidney Disease Drugs Consumed in Chronic Renal Failure
Figure 19. Global Kidney Disease Drugs Market: Chronic Renal Failure (2018-2023) & (K Units)
Figure 20. Kidney Disease Drugs Consumed in Kidney Stones
Figure 21. Global Kidney Disease Drugs Market: Kidney Stones (2018-2023) & (K Units)
Figure 22. Kidney Disease Drugs Consumed in Renal Cyst (polycystic Kidney)
Figure 23. Global Kidney Disease Drugs Market: Renal Cyst (polycystic Kidney) (2018-2023) & (K Units)
Figure 24. Kidney Disease Drugs Consumed in Diabetic Nephropathy
Figure 25. Global Kidney Disease Drugs Market: Diabetic Nephropathy (2018-2023) & (K Units)
Figure 26. Kidney Disease Drugs Consumed in Hypertensive Nephropathy
Figure 27. Global Kidney Disease Drugs Market: Hypertensive Nephropathy (2018-2023) & (K Units)
Figure 28. Kidney Disease Drugs Consumed in Purpura Nephritis
Figure 29. Global Kidney Disease Drugs Market: Purpura Nephritis (2018-2023) & (K Units)
Figure 30. Kidney Disease Drugs Consumed in Lupus Nephritis
Figure 31. Global Kidney Disease Drugs Market: Lupus Nephritis (2018-2023) & (K Units)
Figure 32. Kidney Disease Drugs Consumed in Pediatric Kidney Disease
Figure 33. Global Kidney Disease Drugs Market: Pediatric Kidney Disease (2018-2023) & (K Units)
Figure 34. Global Kidney Disease Drugs Sales Market Share by Application (2022)
Figure 35. Global Kidney Disease Drugs Revenue Market Share by Application in 2022
Figure 36. Kidney Disease Drugs Sales Market by Company in 2022 (K Units)
Figure 37. Global Kidney Disease Drugs Sales Market Share by Company in 2022
Figure 38. Kidney Disease Drugs Revenue Market by Company in 2022 ($ Million)
Figure 39. Global Kidney Disease Drugs Revenue Market Share by Company in 2022
Figure 40. Global Kidney Disease Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 41. Global Kidney Disease Drugs Revenue Market Share by Geographic Region in 2022
Figure 42. Americas Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 43. Americas Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 44. APAC Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 45. APAC Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 46. Europe Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 47. Europe Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 48. Middle East & Africa Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 49. Middle East & Africa Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 50. Americas Kidney Disease Drugs Sales Market Share by Country in 2022
Figure 51. Americas Kidney Disease Drugs Revenue Market Share by Country in 2022
Figure 52. Americas Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 53. Americas Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 54. United States Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Canada Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Mexico Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Brazil Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. APAC Kidney Disease Drugs Sales Market Share by Region in 2022
Figure 59. APAC Kidney Disease Drugs Revenue Market Share by Regions in 2022
Figure 60. APAC Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 61. APAC Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 62. China Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Japan Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. South Korea Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Southeast Asia Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. India Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Australia Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. China Taiwan Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Europe Kidney Disease Drugs Sales Market Share by Country in 2022
Figure 70. Europe Kidney Disease Drugs Revenue Market Share by Country in 2022
Figure 71. Europe Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 72. Europe Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 73. Germany Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. France Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. UK Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Italy Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Russia Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Middle East & Africa Kidney Disease Drugs Sales Market Share by Country in 2022
Figure 79. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Country in 2022
Figure 80. Middle East & Africa Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 81. Middle East & Africa Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 82. Egypt Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 83. South Africa Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 84. Israel Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 85. Turkey Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 86. GCC Country Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 87. Manufacturing Cost Structure Analysis of Kidney Disease Drugs in 2022
Figure 88. Manufacturing Process Analysis of Kidney Disease Drugs
Figure 89. Industry Chain Structure of Kidney Disease Drugs
Figure 90. Channels of Distribution
Figure 91. Global Kidney Disease Drugs Sales Market Forecast by Region (2024-2029)
Figure 92. Global Kidney Disease Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 93. Global Kidney Disease Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 94. Global Kidney Disease Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 95. Global Kidney Disease Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 96. Global Kidney Disease Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Kidney Disease Drugs
Figure 2. Kidney Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Kidney Disease Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Kidney Disease Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Kidney Disease Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsule
Figure 11. Product Picture of Other
Figure 12. Global Kidney Disease Drugs Sales Market Share by Type in 2022
Figure 13. Global Kidney Disease Drugs Revenue Market Share by Type (2018-2023)
Figure 14. Kidney Disease Drugs Consumed in Chronic Glomerulonephritis
Figure 15. Global Kidney Disease Drugs Market: Chronic Glomerulonephritis (2018-2023) & (K Units)
Figure 16. Kidney Disease Drugs Consumed in Nephrotic Syndrome
Figure 17. Global Kidney Disease Drugs Market: Nephrotic Syndrome (2018-2023) & (K Units)
Figure 18. Kidney Disease Drugs Consumed in Chronic Renal Failure
Figure 19. Global Kidney Disease Drugs Market: Chronic Renal Failure (2018-2023) & (K Units)
Figure 20. Kidney Disease Drugs Consumed in Kidney Stones
Figure 21. Global Kidney Disease Drugs Market: Kidney Stones (2018-2023) & (K Units)
Figure 22. Kidney Disease Drugs Consumed in Renal Cyst (polycystic Kidney)
Figure 23. Global Kidney Disease Drugs Market: Renal Cyst (polycystic Kidney) (2018-2023) & (K Units)
Figure 24. Kidney Disease Drugs Consumed in Diabetic Nephropathy
Figure 25. Global Kidney Disease Drugs Market: Diabetic Nephropathy (2018-2023) & (K Units)
Figure 26. Kidney Disease Drugs Consumed in Hypertensive Nephropathy
Figure 27. Global Kidney Disease Drugs Market: Hypertensive Nephropathy (2018-2023) & (K Units)
Figure 28. Kidney Disease Drugs Consumed in Purpura Nephritis
Figure 29. Global Kidney Disease Drugs Market: Purpura Nephritis (2018-2023) & (K Units)
Figure 30. Kidney Disease Drugs Consumed in Lupus Nephritis
Figure 31. Global Kidney Disease Drugs Market: Lupus Nephritis (2018-2023) & (K Units)
Figure 32. Kidney Disease Drugs Consumed in Pediatric Kidney Disease
Figure 33. Global Kidney Disease Drugs Market: Pediatric Kidney Disease (2018-2023) & (K Units)
Figure 34. Global Kidney Disease Drugs Sales Market Share by Application (2022)
Figure 35. Global Kidney Disease Drugs Revenue Market Share by Application in 2022
Figure 36. Kidney Disease Drugs Sales Market by Company in 2022 (K Units)
Figure 37. Global Kidney Disease Drugs Sales Market Share by Company in 2022
Figure 38. Kidney Disease Drugs Revenue Market by Company in 2022 ($ Million)
Figure 39. Global Kidney Disease Drugs Revenue Market Share by Company in 2022
Figure 40. Global Kidney Disease Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 41. Global Kidney Disease Drugs Revenue Market Share by Geographic Region in 2022
Figure 42. Americas Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 43. Americas Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 44. APAC Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 45. APAC Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 46. Europe Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 47. Europe Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 48. Middle East & Africa Kidney Disease Drugs Sales 2018-2023 (K Units)
Figure 49. Middle East & Africa Kidney Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 50. Americas Kidney Disease Drugs Sales Market Share by Country in 2022
Figure 51. Americas Kidney Disease Drugs Revenue Market Share by Country in 2022
Figure 52. Americas Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 53. Americas Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 54. United States Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Canada Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Mexico Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Brazil Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. APAC Kidney Disease Drugs Sales Market Share by Region in 2022
Figure 59. APAC Kidney Disease Drugs Revenue Market Share by Regions in 2022
Figure 60. APAC Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 61. APAC Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 62. China Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Japan Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. South Korea Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Southeast Asia Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. India Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Australia Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. China Taiwan Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Europe Kidney Disease Drugs Sales Market Share by Country in 2022
Figure 70. Europe Kidney Disease Drugs Revenue Market Share by Country in 2022
Figure 71. Europe Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 72. Europe Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 73. Germany Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. France Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. UK Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Italy Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Russia Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Middle East & Africa Kidney Disease Drugs Sales Market Share by Country in 2022
Figure 79. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Country in 2022
Figure 80. Middle East & Africa Kidney Disease Drugs Sales Market Share by Type (2018-2023)
Figure 81. Middle East & Africa Kidney Disease Drugs Sales Market Share by Application (2018-2023)
Figure 82. Egypt Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 83. South Africa Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 84. Israel Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 85. Turkey Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 86. GCC Country Kidney Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 87. Manufacturing Cost Structure Analysis of Kidney Disease Drugs in 2022
Figure 88. Manufacturing Process Analysis of Kidney Disease Drugs
Figure 89. Industry Chain Structure of Kidney Disease Drugs
Figure 90. Channels of Distribution
Figure 91. Global Kidney Disease Drugs Sales Market Forecast by Region (2024-2029)
Figure 92. Global Kidney Disease Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 93. Global Kidney Disease Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 94. Global Kidney Disease Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 95. Global Kidney Disease Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 96. Global Kidney Disease Drugs Revenue Market Share Forecast by Application (2024-2029)
